Category Archives: Uncategorized

Research provides new insights into diabetic retinopathy risk

macro human eye
People with diabetes could reduce their risk of diabetic retinopathy for every hour they achieve target blood glucose levels, research suggests.Chinese researchers reported the association following a study of 3,262 people with type 2 diabetes. A total of 780 people in the study had diabetic retinopathy before it began. On average, the participants were aged 60 years and had elevated average HbA1c readings of 74 mmol/mol (8.9%). They wore continuous glucose monitors for a three-day period and had their time measured in .

Heart disease risk is lower in frail people who exercise more, study suggests

Doing exercise reduces the risk of older people developing frailty and can lead to a longer life, research from Spain has suggested.There have been calls for individualised care to be rolled out for older people with diabetes, who are more at risk of becoming frail. And previously, the benefits of physical activity have been shown to reduce falls and improve walking, balance and muscle strength.Exercise has also shown to be able to improve health for people with type .

Weight gain from childhood to adulthood could impact type 2 diabetes risk

The rate of weight gain from childhood to adulthood could impact type 2 diabetes risk differently to having high body mass index (BMI) throughout life, research suggests.More and more children are being diagnosed with type 2 diabetes, and efforts are being made to combat this trend. The government has made a series of proposals to challenge childhood obesity – which significantly increases the risk of type 2 – and cutting down on sugar and junk food has shown to be essential for physical and .

Type 2 makes up more than 90 per cent of diabetes diagnoses in America

A study looking at current diabetes rates in the US has shown that the proportion of people with diabetes that have type 2 is above 90 per cent.The University of Iowa has found that of those who have diabetes mellitus (diabetes resulting in high blood sugar), 91.2 per cent have type 2 diabetes, 5.6 per cent have type 1 diabeteswith the remainder making up a number of other types of diabetes.According to the American Diabetes Association there are 30 million people .

Go to bed at the same time each night, researchers say

Woman sleeping in a bed in a dark bedroom
Going to bed at the same time each night could have benefits for the heart and metabolism, a US study suggests.Getting good quality sleep has long been linked to improved health, while sleep irregularity is thought to be linked to obesityand an increased risk of type 2 diabetes.Scientists from the Duke University Medical Center, based in North Carolina, studied the sleeping patterns of almost 2,000 people aged 54-93, none of whom had any history of sleepdisorders.The participants wore devices .

One blood test may be enough to accurately diagnose type 2 diabetes.

The way type 2 diabetes is diagnosed could be simplified in the future after US researchers say one blood test is sufficient to identity the condition.At the moment two blood tests are required to determine a diagnosis. But now a team from the Bloomberg School in Maryland, US, say they think just one solitary test is enough to accurately diagnose someone. The researchers recruited 12,268 participants without diagnosed diabetes from the Atherosclerosis Risk in Communities study – .

Oral type 1 diabetes medication under FDA review in US

Woman taking pills. Depressed young woman taking a pill while standing against grey background
An oral type 1 diabetes drug that can be taken alongside insulin is set to be reviewed by the US Food and Drug Administration (FDA).Sotagliflozin (marketed as Zynquista), made by pharmaceutical companies Sanofi and Lexicon, is a dual SGLT1 and SGLT2 inhibitor. This means this one tablet has two different functions. The SGLT1 inhibitor part of the drug works by delaying the process of glucose being absorbed by the intestines, which helps avoid the .

Dexcom’s integrated CGM receives FDA nod

Dexcom got the nod from the FDA to market their Dexcom G6, an integrated continuous glucose monitoring system (iCGM), making it the first interoperable CGM to get the designation. “We are a company of firsts, almost everything that has been done in our industry has been done by us first,” Dexcom CEO Kevin Sayer told MobiHealthNews, citing that Dexcom was the first company to have a seven day sensor and to connect to a .

CGMs improve quality of life for people with type 1 diabetes

Continuous glucose monitoring with a sensor. The transmitter sends every 5 minutes the blood sugar level to the receiver hanging on the belt.
Continuous glucose monitors (CGMs) can significantly enrich the lives of people with type 1 diabetes, US researchers state. A six-month trial monitoring people who used CGMs showed the devices improved blood sugar control, reduced hypoglycemia and improved overall quality of life. Senior study author Dr Elbert Huang, associate director of the Chicago Center for Diabetes Translation Research, said: “If you map out the lifetime of a patient, it’s impressive. The CGM adds years of .

FreeStyle Libre acclaimed as game changer in an independent assessment

The FreeStyle Libre from Abbott Diabetes Care has been described as a ‘game changer’ and ‘life-saving’ in most patients by the authors of an independent assessment of the device. The FreeStyle Libre is a flash glucose monitoring device that can provide glucose levels and glucose level trend charts that reduces the need for finger-prick blood glucose tests. People with type 1 diabetes typically need to take between 4 and 10 blood glucose tests per .